Wireless Power and Wearable Systems in Modern PNS

The architecture of implantable neurostimulation has undergone a significant evolution over the past decade. Earlier systems required large, fully implanted pulse generators containing batteries, electronics, and housing — devices substantial enough to create visible bulges under the skin and requiring surgical replacement as batteries depleted.

A newer class of PNS systems separates power and control from the implanted component entirely. The implant is reduced to its essential function: receiving power wirelessly and delivering stimulation to the target nerve. Everything else — the battery, the control electronics, the programming interface — lives in a wearable external device.

Power delivery from external to implanted components occurs through electromagnetic induction — the same fundamental principle used in wireless phone charging. The external wearable device generates an oscillating magnetic field; the implanted receiver contains a coil that converts this field into electrical current, which drives the stimulation delivered to the target nerve.

The external transmitter and implanted receiver must be positioned in proximity for efficient power transfer — typically aligned over the implant site, often achievable through clothing. This design allows for real-world use during daily activities: the patient positions the wearable, activates therapy, and the system functions through the skin without requiring any percutaneous connection.

With power and control removed from the implant body, the implanted component can be miniaturized to a degree not possible in traditional self-powered systems. Current externally powered implants include microstimulators that are orders of magnitude smaller than conventional implantable pulse generators — small enough that they are minimally palpable and rarely visible beneath the skin.

This miniaturization has meaningful clinical benefits. Smaller implants require smaller incisions, create less tissue disruption at placement, carry lower infection risk due to reduced implant surface area, and produce less discomfort at the implant site. The procedure is correspondingly simpler — outpatient, minimal anesthesia, short recovery.

In addition to delivering power, the external wearable serves as the interface between the patient and their therapy. Stimulation parameters — frequency, pulse width, amplitude, and therapy schedules — are controlled through the external device, often via a companion app on a smartphone or dedicated controller.

This design means that adjustments to therapy — including optimization of stimulation parameters as the patient's needs evolve — can be made without any invasive procedure. The physician or clinic can adjust settings remotely or at a follow-up visit, and patients can manage day-to-day therapy parameters within prescribed limits using their own device.

One of the most clinically significant implications of this architecture is the potential for therapeutic upgradeability without surgical revision. As neurostimulation research advances — new waveforms, optimized frequencies, refined targeting algorithms — these improvements can in principle be delivered through updates to the external device.

For a patient implanted today, this means the therapy they access in five years may be meaningfully improved from what was available at the time of their implant — without any additional surgery. The implanted receiver functions as a stable platform; the external interface evolves. This is a fundamentally different model from the traditional one, where improvements required surgical hardware revision.

Using an externally powered PNS system requires maintaining and wearing the external component during therapy sessions. For most patients, the device is small enough to be worn discreetly under clothing. Therapy can be delivered during regular activities — work, walking, light exercise — without significantly interrupting daily routine.

When not using the device, the external component can be removed entirely. The implanted portion remains inactive but in place, ready to receive power when the external device is reapplied. This on/off flexibility gives patients control over when and how they engage with their therapy, which most patients find preferable to a system that cannot be paused.